(Q37137006)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407735%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

Translational research in glioblastoma multiforme: molecular criteria for patient selection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407735%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407735%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Santiago Ramon y Cajal

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407735%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

Ramon de Las Peñas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407735%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Mariacarmela Santarpia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407735%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Fernanda Salazar

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407735%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Itziar de Aguirre

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407735%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Noemi Reguart

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407735%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Salvador Villa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407735%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Jia Wei

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407735%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Jose Luis Ramirez

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407735%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Miguel Angel Molina

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407735%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

David Jablons

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407735%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Miquel Taron

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407735%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Rafael Rosell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407735%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

English

0 references

publication date

1 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407735%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407735%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407735%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407735%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

219-228

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407735%20AND%20SRC:MED&resulttype=core&format=json

The WHO classification of tumors of the nervous system

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Consensus conference on cancer registration of brain and central nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Phosphorylated Pak1 level in the cytoplasm correlates with shorter survival time in patients with glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Overall survival in patients with malignant glioma may be significantly longer with tumors located in deep grey matter.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Evaluation of the 3p21.3 tumour-suppressor gene cluster

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Insulin growth factor-binding protein 2 is a candidate biomarker for PTEN status and PI3K/Akt pathway activation in glioblastoma and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Insulin-like growth factor binding protein 2 promotes glioma development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Scaffolding protein Grb2-associated binder 1 sustains epidermal growth factor-induced mitogenic and survival signaling by multiple positive feedback loops

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

The scaffolding adapter Gab1 mediates vascular endothelial growth factor signaling and is required for endothelial cell migration and capillary formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Targeting neuropilin 1 as an antitumor strategy in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Neural stem cells and the origin of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

The role of Wnt signaling in cancer and stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Human Dkk-1, a gene encoding a Wnt antagonist, responds to DNA damage and its overexpression sensitizes brain tumor cells to apoptosis following alkylation damage of DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Mechanisms of disease: genetic predictors of response to treatment in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Ubiquitin-binding protein RAP80 mediates BRCA1-dependent DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Abraxas and RAP80 form a BRCA1 protein complex required for the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Roles of CHOP/GADD153 in endoplasmic reticulum stress

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Compressing drug development timelines in oncology using phase '0' trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

Roles for negative cell regulator 14-3-3σ in control of MDM2 activities

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796694.4.2.219

21 January 2018

Identifiers

DOI

10.2217/14796694.4.2.219

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18407735%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference